FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

 OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Smith Douglas Baker 2. Date of Event Requiring Statement (MM/DD/YYYY)
5/3/2019 

 3. Issuer Name and Ticker or Trading Symbol theMaven, Inc. [MVEN]
(Last)       (First)       (Middle)
225 LIBERTY STREET, 27TH FLOOR		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Financial Officer /
(Street)
NEW YORK, NY 10281      
(City)             (State)             (Zip)
 5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

 6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase  3/11/2020 (1) 2/11/2029  Common Stock  1500000  $0.57  D   
Options to purchase  12/18/2020 (3) 4/10/2029  Common Stock  1064008 (2) $0.46  D   

Explanation of Responses:
(1)  1/3 vests after 1 year. Balance vests monthly over next 2 years.
(2)  Grant vests 1/3 after first year. Balance monthly over next 2 years.
(3)  The ability to exercise is subject to both: i) vesting conditions (2) and ii) the Issuer's stockholders approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant; such requisite increased was approved as of December 18, 2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Smith Douglas Baker
225 LIBERTY STREET, 27TH FLOOR
NEW YORK, NY 10281

Chief Financial Officer

Signatures
/s/ Douglas Baker Smith 2/3/2021
**Signature of Reporting Person Date